Market Overview:
The global targeted DNA/RNA sequencing market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The market growth is attributed to the increasing demand for targeted sequencing in human biomedical research, plant & animal sciences, drug discovery, and other applications. Additionally, the growing demand for Next-Generation Sequencing (NGS) platforms is also contributing to the growth of this market. However, the high cost of NGS platforms may restrain the growth of this market during the forecast period. The DNA-based targeted sequencing segment accounted for a major share of the global target DNA/RNA sequencing market in 2017 and is expected to maintain its dominance during the forecast period. This segment is mainly driven by rising demand from human biomedical research applications.
Product Definition:
Targeted DNA sequencing is a technique used to sequence specific regions of DNA. This technique can be used to identify mutations in a particular gene or to determine the sequence of a specific DNA fragment. Targeted RNA sequencing is similar to targeted DNA sequencing, but uses RNA instead of DNA. The use of targeted sequencing can help researchers understand the function of genes and how they are regulated.
DNA-based Targeted Sequencing:
DNA-based targeted sequencing is a process where DNA or RNA sequence of interest is identified by the use of specific probes. These probes are complementary to unique sequences in the genome and once bound, they enable us to sequence DNA orRNA at that location.
RNA-based Targeted Sequencing:
RNA-based targeted sequencing is a new technology that allows the isolation of specific RNA samples from biological samples. It also allows quantification and analysis of the target RNA in a single step. This technology has been used to analyze gene expression, splicing, microRNA processing and post-translational modification of specific nucleic acids.
Application Insights:
Drug discovery application segment is projected to grow at a CAGR of XX% over the forecast period owing to its wide-spread usage in screening and identification of drug targets in various organisms, including human, plants & animals and microbes. Furthermore, this technology helps identify potential side effects caused by drugs before they are administered to patients which is expected to boost its adoption for drug discovery applications.
Plant & animal sciences are also anticipated to witness significant growth with a CAGR exceeding 14%. This technology aids plant breeders in identifying molecular markers that can be used for breeding purposes as well as help identify pathogens or pests affecting crops leading to an increase in demand for plant science research using this technique. Moreover targeted genes within the plants can be used for producing biofuels which further drives the growth of this market segment.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a well-established healthcare infrastructure, availability of skilled professionals, and high adoption rate for technologically advanced products. Moreover, increasing focus on drug discovery & development activities coupled with rising prevalence of cancer is expected to drive this regional market over the forecast period.
Asia Pacific is estimated to witness lucrative growth during the forecast period owing to growing interest from pharmaceutical companies in emerging markets such as China and India for drug discovery & development activities. In addition, supportive government initiatives aimed at improving healthcare facilities are anticipated to propel revenue generation in this region over the next eight years.
Growth Factors:
- Increasing demand for personalized medicine
- Growing number of cancer patients
- Rising prevalence of genetic disorders
- Technological advancements in sequencing platforms and bioinformatics tools
- Growing investments in life sciences research
Scope Of The Report
Report Attributes
Report Details
Report Title
Targeted DNA/RNA Sequencing Market Research Report
By Type
DNA-based Targeted Sequencing, RNA-based Targeted Sequencing
By Application
Human Biomedical Research, Plant & Animal Sciences, Drug Discovery, Others
By Companies
Illumina, Inc., F. Hoffmann-La Roche Ltd, Agilent Technologies, GATC Biotech Ag, Oxford Nanopore Technologies, Thermo Fisher Scientific, Inc., DNASTAR Inc., QIAGEN, BGI, Perkin Elmer, Inc., Pacific Biosciences of California, Inc., Bio-Rad Laboratories, Inc., Integrated DNA Technologies, Inc., RainDance Technologies, Inc., PierianDx, Genomatix GmbH, Macrogen, Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
162
Number of Tables & Figures
114
Customization Available
Yes, the report can be customized as per your need.
Global Targeted DNA/RNA Sequencing Market Report Segments:
The global Targeted DNA/RNA Sequencing market is segmented on the basis of:
Types
DNA-based Targeted Sequencing, RNA-based Targeted Sequencing
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Human Biomedical Research, Plant & Animal Sciences, Drug Discovery, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Illumina, Inc.
- F. Hoffmann-La Roche Ltd
- Agilent Technologies
- GATC Biotech Ag
- Oxford Nanopore Technologies
- Thermo Fisher Scientific, Inc.
- DNASTAR Inc.
- QIAGEN
- BGI
- Perkin Elmer, Inc.
- Pacific Biosciences of California, Inc.
- Bio-Rad Laboratories, Inc.
- Integrated DNA Technologies, Inc.
- RainDance Technologies, Inc.
- PierianDx
- Genomatix GmbH
- Macrogen, Inc.
Highlights of The Targeted DNA/RNA Sequencing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- DNA-based Targeted Sequencing
- RNA-based Targeted Sequencing
- By Application:
- Human Biomedical Research
- Plant & Animal Sciences
- Drug Discovery
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Targeted DNA/RNA Sequencing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Targeted DNA/RNA sequencing is a type of genetic sequencing that uses specific sequences of DNA or RNA to identify particular genes. This approach can be more accurate than traditional genetic sequencing, which looks at the entire genome.
Some of the major companies in the targeted dna/rna sequencing market are Illumina, Inc., F. Hoffmann-La Roche Ltd, Agilent Technologies, GATC Biotech Ag, Oxford Nanopore Technologies, Thermo Fisher Scientific, Inc., DNASTAR Inc., QIAGEN, BGI, Perkin Elmer, Inc., Pacific Biosciences of California, Inc., Bio-Rad Laboratories, Inc., Integrated DNA Technologies, Inc., RainDance Technologies, Inc., PierianDx, Genomatix GmbH, Macrogen, Inc..
The targeted dna/rna sequencing market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Targeted DNA/RNA Sequencing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Targeted DNA/RNA Sequencing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Targeted DNA/RNA Sequencing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Targeted DNA/RNA Sequencing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Targeted DNA/RNA Sequencing Market Size & Forecast, 2018-2028
4.5.1 Targeted DNA/RNA Sequencing Market Size and Y-o-Y Growth
4.5.2 Targeted DNA/RNA Sequencing Market Absolute $ Opportunity
Chapter 5 Global Targeted DNA/RNA Sequencing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Targeted DNA/RNA Sequencing Market Size Forecast by Type
5.2.1 DNA-based Targeted Sequencing
5.2.2 RNA-based Targeted Sequencing
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Targeted DNA/RNA Sequencing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Targeted DNA/RNA Sequencing Market Size Forecast by Applications
6.2.1 Human Biomedical Research
6.2.2 Plant & Animal Sciences
6.2.3 Drug Discovery
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Targeted DNA/RNA Sequencing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Targeted DNA/RNA Sequencing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Targeted DNA/RNA Sequencing Analysis and Forecast
9.1 Introduction
9.2 North America Targeted DNA/RNA Sequencing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Targeted DNA/RNA Sequencing Market Size Forecast by Type
9.6.1 DNA-based Targeted Sequencing
9.6.2 RNA-based Targeted Sequencing
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Targeted DNA/RNA Sequencing Market Size Forecast by Applications
9.10.1 Human Biomedical Research
9.10.2 Plant & Animal Sciences
9.10.3 Drug Discovery
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Targeted DNA/RNA Sequencing Analysis and Forecast
10.1 Introduction
10.2 Europe Targeted DNA/RNA Sequencing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Targeted DNA/RNA Sequencing Market Size Forecast by Type
10.6.1 DNA-based Targeted Sequencing
10.6.2 RNA-based Targeted Sequencing
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Targeted DNA/RNA Sequencing Market Size Forecast by Applications
10.10.1 Human Biomedical Research
10.10.2 Plant & Animal Sciences
10.10.3 Drug Discovery
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Targeted DNA/RNA Sequencing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Targeted DNA/RNA Sequencing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Targeted DNA/RNA Sequencing Market Size Forecast by Type
11.6.1 DNA-based Targeted Sequencing
11.6.2 RNA-based Targeted Sequencing
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Targeted DNA/RNA Sequencing Market Size Forecast by Applications
11.10.1 Human Biomedical Research
11.10.2 Plant & Animal Sciences
11.10.3 Drug Discovery
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Targeted DNA/RNA Sequencing Analysis and Forecast
12.1 Introduction
12.2 Latin America Targeted DNA/RNA Sequencing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Targeted DNA/RNA Sequencing Market Size Forecast by Type
12.6.1 DNA-based Targeted Sequencing
12.6.2 RNA-based Targeted Sequencing
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Targeted DNA/RNA Sequencing Market Size Forecast by Applications
12.10.1 Human Biomedical Research
12.10.2 Plant & Animal Sciences
12.10.3 Drug Discovery
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Targeted DNA/RNA Sequencing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Targeted DNA/RNA Sequencing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Targeted DNA/RNA Sequencing Market Size Forecast by Type
13.6.1 DNA-based Targeted Sequencing
13.6.2 RNA-based Targeted Sequencing
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Targeted DNA/RNA Sequencing Market Size Forecast by Applications
13.10.1 Human Biomedical Research
13.10.2 Plant & Animal Sciences
13.10.3 Drug Discovery
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Targeted DNA/RNA Sequencing Market: Competitive Dashboard
14.2 Global Targeted DNA/RNA Sequencing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Illumina, Inc.
14.3.2 F. Hoffmann-La Roche Ltd
14.3.3 Agilent Technologies
14.3.4 GATC Biotech Ag
14.3.5 Oxford Nanopore Technologies
14.3.6 Thermo Fisher Scientific, Inc.
14.3.7 DNASTAR Inc.
14.3.8 QIAGEN
14.3.9 BGI
14.3.10 Perkin Elmer, Inc.
14.3.11 Pacific Biosciences of California, Inc.
14.3.12 Bio-Rad Laboratories, Inc.
14.3.13 Integrated DNA Technologies, Inc.
14.3.14 RainDance Technologies, Inc.
14.3.15 PierianDx
14.3.16 Genomatix GmbH
14.3.17 Macrogen, Inc.
